NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE102383 Query DataSets for GSE102383
Status Public on Jul 05, 2019
Title Trunk events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma [sHCC1]
Organism Homo sapiens
Experiment type Expression profiling by array
Summary Introduction: According to the clonal model of tumor evolution, trunk alterations arise at early stages and are ubiquitous. Through the characterization of early stages of hepatocarcinogenesis, we aimed to identify trunk alterations in HCC and study their intra- and inter-tumor distribution in more advanced lesions. Methods: 151 samples representing the multi-step process of hepatocarcinogenesis were analyzed by targeted-sequencing and SNP array. Genes altered in early lesions [31 dysplastic nodules (DNs) and 38 small HCCs (sHCC)] were defined as trunk. The distribution of candidate trunk genes was explored in: a) different regions of large tumors [43 regions of 21 tumors, (2-3 regions/tumor)]; and b) different nodules of the same patient [39 multinodular tumors from 17 patients]. Multinodular lesions were classified as intrahepatic metastases (IMs) or synchronous tumors based on chromosomal aberrations. Results: TERT promoter mutations (10.5%) and broad copy-number aberrations in chromosomes 1 and 8 (3-7%) were identified as trunk gatekeepers in DNs and were maintained in sHCCs. Trunk drivers identified in sHCCs included TP53 (23%) and CTNNB1 (11%) mutations, and focal amplifications or deletions in known drivers (6%). Overall, TERT, TP53 and CTNNB1 mutations were the most frequent trunk events in early stages. 89% of mutations in these genes were shared between different regions of large tumors. In multinodular HCCs, 35% of patients harbored IMs. 85% of mutations in TERT, TP53 and/or CTNNB1 were retained in primary and metastatic tumors. Conclusions: Trunk events in early stages (TERT, TP53, CTNNB1 mutations) were ubiquitous across different regions of the same tumor and between primary and metastatic nodules in >85% of cases. This concept supports the knowledge that single biopsies would suffice to capture trunk mutations in HCC.
 
Overall design Paraffin-embedded tumors and dysplasias from 19 patients were collected and RNA was extracted. Matched non-tumor cirrrhotic tissue was also collected for all cases. 6 non-tumoral and non-cirrhotic liver tissues were alsco included as controls. Whole-genome trasncriptome analysis was done using HumanHT-12 WG-DASL V4.0 R2 expression beadchip (Illumina) according to manufacturer’s protocols. Raw data were normalized using cubic spline algorithm implemented in the Illumina Normalizer module of the GenePattern analysis toolkit (www.broadinstitute.org/genepattern) as previously described (Sia D et al, Gastroenterology, 2013).
 
Contributor(s) Llovet JM, Sia D
Citation(s) 28843658
Submission date Aug 08, 2017
Last update date Jul 06, 2019
Contact name Sara Torrecilla
Organization name IDIBAPS
Lab Liver Cancer Translational Research Laboratory
Street address Rossello Street, 149
City Barcelona
State/province Catalonia
ZIP/Postal code 08036
Country Spain
 
Platforms (1)
GPL18281 Illumina HumanHT-12 WG-DASL V4.0 R2 expression beadchip [gene symbol version]
Samples (69)
GSM2735814 sHCC-Pt54
GSM2735815 sHCC-Pt55
GSM2735816 sHCC-Pt56
This SubSeries is part of SuperSeries:
GSE98620 Trunk events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma
Relations
BioProject PRJNA397758

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE102383_Expression-sHCC1-Non_normalized.txt.gz 8.6 Mb (ftp)(http) TXT
Raw data are available on Series record
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap